<DOC>
	<DOCNO>NCT00048425</DOCNO>
	<brief_summary>The purpose study evaluate efficacy 24-hour infusion levosimendan compare placebo treatment decompensated chronic heart failure .</brief_summary>
	<brief_title>Evaluation Intravenous Levosimendan Efficacy Short Term Treatment Decompensated Chronic Heart Failure .</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>A write informed consent must obtain hospitalize male female patient 18 year old age . The eligible patient must diagnose worsen heart failure evidence dyspnea rest , poor ejection fraction treat IV diuretic . It allowable patient treat IV inotropes vasodilator . The following criterion would exclude patient study : invasive cardiac procedure ( e.g . cardiac surgery , LVAD , cardioversion , cardiac resynchronization ) , rhythm disorder ( e.g . early Torsades de Pointes , increase heart rate ) , severe ventricular outflow obstruction , angina , hypotension , uncorrected hypokalemia , CNS ( e.g . stroke , TIA ) , respiratory ( e.g . COPD , intubate patient , oral , intravenous intramuscular steroid ) , renal insufficiency ( e.g . increase serum creatinine , dialysis ) , hepatic impairment ( e.g . significant increase liver enzymes ) , decompensation active infection acute bleeding ( e.g . severe anemia ) . Female patient child bear potential must negative pregnancy test use adequate contraceptive precaution . Also exclude use amrinone milrinone prior randomization , history hypersensitivity levosimendan excipients previous participation clinical trial experimental treatment within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
	<keyword>Decompensated chronic heart failure</keyword>
</DOC>